Lataa...
CAR T Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
The durable remission of B-cell leukemia and lymphoma following chimeric antigen receptor T (CART) cell therapy has brought this new form of adoptive immunotherapy to center stage with the expectation that CART cell therapy may provide similar efficacy in other hematological and solid cancers. Herei...
Tallennettuna:
| Julkaisussa: | Cancer J |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4656124/ https://ncbi.nlm.nih.gov/pubmed/26588679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000155 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|